Literature DB >> 8892904

Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

J Weber1, E M Fenyö, S Beddows, P Kaleebu, A Björndal.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) primary isolates from four geographical locations in Thailand, Brazil, Rwanda, and Uganda, representing genetic subtypes A, B, C, D, and E, were examined for autologous and heterologous neutralization by panels of human HIV+ polyclonal plasma. In independent linked experiments in three laboratories using diverse methodologies and common reagents, no defined pattern of genetic subtype-specific neutralization was observed. Most plasma tested were broadly cross-neutralizing across two or more genetic subtypes, although the titer of neutralization varied across a wide range. We conclude that the genetic subtypes of HIV-1 are not classical neutralization serotypes.

Entities:  

Mesh:

Year:  1996        PMID: 8892904      PMCID: PMC190853     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.

Authors:  M P D'Souza; G Milman; J A Bradac; D McPhee; C V Hanson; R M Hendry
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

2.  Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers.

Authors:  J Weber; R Cheinsong-Popov; D Callow; S Adams; G Patou; K Hodgkin; S Martin; F Gotch; A Kingsman
Journal:  Vaccine       Date:  1995-06       Impact factor: 3.641

3.  Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial.

Authors:  S A Fiscus; V DeGruttola; P Gupta; D A Katzenstein; W A Meyer; M L LoFaro; M Katzman; M V Ragni; P S Reichelderfer; R W Coombs
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

4.  Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.

Authors:  J Louwagie; F E McCutchan; M Peeters; T P Brennan; E Sanders-Buell; G A Eddy; G van der Groen; K Fransen; G M Gershy-Damet; R Deleys
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

5.  Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.

Authors:  R Cheingsong-Popov; S Lister; D Callow; P Kaleebu; S Beddows; J Weber
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

6.  Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

Authors:  L S Sawyer; M T Wrin; L Crawford-Miksza; B Potts; Y Wu; P A Weber; R D Alfonso; C V Hanson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

Authors:  E L Delwart; E G Shpaer; J Louwagie; F E McCutchan; M Grez; H Rübsamen-Waigmann; J I Mullins
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

8.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

Authors:  J P Moore; Y Cao; J Leu; L Qin; B Korber; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.

Authors:  L G Kostrikis; Y Cao; H Ngai; J P Moore; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.

Authors:  F Gao; L Yue; S Craig; C L Thornton; D L Robertson; F E McCutchan; J A Bradac; P M Sharp; B H Hahn
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

View more
  34 in total

1.  Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV.

Authors:  S Zolla-Pazner; M K Gorny; P N Nyambi; T C VanCott; A Nádas
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Authors:  J P Moore; P W Parren; D R Burton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.

Authors:  F Verrier; S Burda; R Belshe; A M Duliege; J L Excler; M Klein; S Zolla-Pazner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Population dynamics of HIV-1 inferred from gene sequences.

Authors:  N C Grassly; P H Harvey; E C Holmes
Journal:  Genetics       Date:  1999-02       Impact factor: 4.562

6.  Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Authors:  Hong Shang; Xiaoxu Han; Xuanling Shi; Teng Zuo; Mark Goldin; Dan Chen; Bing Han; Wei Sun; Hao Wu; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

7.  Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

Authors:  Peter Hraber; Bette T Korber; Alan S Lapedes; Robert T Bailer; Michael S Seaman; Hongmei Gao; Kelli M Greene; Francine McCutchan; Carolyn Williamson; Jerome H Kim; Sodsai Tovanabutra; Beatrice H Hahn; Ronald Swanstrom; Michael M Thomson; Feng Gao; Linda Harris; Elena Giorgi; Nicholas Hengartner; Tanmoy Bhattacharya; John R Mascola; David C Montefiori
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

8.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.

Authors:  Nicole A Doria-Rose; Rachel M Klein; Marcus G Daniels; Sijy O'Dell; Martha Nason; Alan Lapedes; Tanmoy Bhattacharya; Stephen A Migueles; Richard T Wyatt; Bette T Korber; John R Mascola; Mark Connors
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.

Authors:  D Cecilia; V N KewalRamani; J O'Leary; B Volsky; P Nyambi; S Burda; S Xu; D R Littman; S Zolla-Pazner
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.